Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9503]

AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers

Dr Marina De Brot - A.C. Camargo Cancer Center, São Paulo, Brazil

AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers ( Dr Marina De Brot - A.C. Camargo Cancer Center, São Paulo, Brazil )

Long-term infusion of dinutuximab beta improves survival in high-risk...

Dr Ruth Ladenstein - St. Anna Children's Hospital, Vienna, Austria

Long-term infusion of dinutuximab beta improves survival in high-risk neuroblastoma ( Dr Ruth Ladenstein - St. Anna Children's Hospital, Vienna, Austria )

Relacorilant plus chemo improves PFS and OS vs chemo alone in platinum...

Dr Brian Slomovitz - Mount Sinai Medical Center, Miami Beach, USA

Relacorilant plus chemo improves PFS and OS vs chemo alone in platinum-resistant ovarian cancer ( Dr Brian Slomovitz - Mount Sinai Medical Center, Miami Beach, USA )

Barriers to global oncology clinical trial participation in sub-Saharan Africa

Dr Oyepeju Folashade Abioye - Allegheny Health Network, Pittsburgh, USA

Barriers to global oncology clinical trial participation in sub-Saharan Africa ( Dr Oyepeju Folashade Abioye - Allegheny Health Network, Pittsburgh, USA )

Social determinants and survival outcomes in early-onset colorectal cancer in...

Dr Jessica Paulus - Ontada, Boston, USA

Social determinants and survival outcomes in early-onset colorectal cancer in the US ( Dr Jessica Paulus - Ontada, Boston, USA )

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers...

Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora...

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform ( Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora, USA )

Molecular assay may help identify NSCLC patients who could benefit from...

Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA

Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy ( Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA )

GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related...

Dr Lucas A Mavromatis - NYU Grossman School of Medicine, New York, USA

GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for diabetics ( Dr Lucas A Mavromatis - NYU Grossman School of Medicine, New York, USA )

QoL improvements ID'd in phase 3 ARANOTE trial for mHSPC

Dr Alicia Morgans - Dana-Farber Cancer Institute, Boston, USA

QoL improvements ID'd in phase 3 ARANOTE trial for mHSPC ( Dr Alicia Morgans - Dana-Farber Cancer Institute, Boston, USA )

Trastuzumab deruxtecan plus pertuzumab may delay cancer growth for some HER2...

Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA

Trastuzumab deruxtecan plus pertuzumab may delay cancer growth for some HER2-positive advanced breast cancers ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )

Rusfertide shows promise for polycythemia vera treatment

Dr Andrew Kuykendall - Moffitt Cancer Center, Tampa, USA

Rusfertide shows promise for polycythemia vera treatment ( Dr Andrew Kuykendall - Moffitt Cancer Center, Tampa, USA )

Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract...

Dr Thorsten Oliver Goetze - The University Cancer Center (UCT), Frankfurt...

Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract cancer ( Dr Thorsten Oliver Goetze - The University Cancer Center (UCT), Frankfurt, Germany )

More from ecancer